data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
Watch
YouTube
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Bio-Techne
(NASDAQ:TECH)
$361.47
-8.59[-2.32%]
Last update: 3:27PM
Day High/Low361.2 - 370.25
52 Week High/Low318.07 - 519.05
Open / Close365.95 / -
Float / Outstanding- / 39.2M
Vol / Avg.100.9K / 227.7K
Mkt Cap14.2B
P/E55.82
50d Avg. Price358.6
Div / Yield1.28/0.35%
Payout Ratio19.31
EPS1.57
Total Float34.4M

Bio-Techne (NASDAQ:TECH), Quotes and News Summary

Bio-Techne (NASDAQ: TECH)

Day High/Low361.2 - 370.25
52 Week High/Low318.07 - 519.05
Open / Close365.95 / -
Float / Outstanding- / 39.2M
Vol / Avg.100.9K / 227.7K
Mkt Cap14.2B
P/E55.82
50d Avg. Price358.6
Div / Yield1.28/0.35%
Payout Ratio19.31
EPS1.57
Total Float34.4M
Sector: Health Care.Industry: Life Sciences Tools & Services
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read More

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2022-11-01
REV
Q4 2022Est.ActualSurprise
EPS2.0802.050 -0.0300
REV287.120M288.229M1.109M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Bio-Techne Questions & Answers

Q
How do I buy Bio-Techne (TECH) stock?
A

You can purchase shares of Bio-Techne (NASDAQ: TECH) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Bio-Techne's (TECH) competitors?
Q
What is the target price for Bio-Techne (TECH) stock?
A

The latest price target for Bio-Techne (NASDAQ: TECH) was reported by Wells Fargo on Tuesday, August 16, 2022. The analyst firm set a price target for 360.00 expecting TECH to fall to within 12 months (a possible -0.41% downside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Bio-Techne (TECH)?
A

The stock price for Bio-Techne (NASDAQ: TECH) is $361.47 last updated Today at August 17, 2022, 7:27 PM UTC.

Q
Does Bio-Techne (TECH) pay a dividend?
A

A quarterly cash dividend of $0.32 per share of Class A Common Stock. The quarterly cash dividend was payable on August 29, 2022 to stockholders of record on August 12, 2022.

Q
When is Bio-Techne (NASDAQ:TECH) reporting earnings?
A

Bio-Techne’s Q1 earnings are confirmed for Tuesday, November 1, 2022.

Q
Is Bio-Techne (TECH) going to split?
A

There is no upcoming split for Bio-Techne.

Q
What sector and industry does Bio-Techne (TECH) operate in?
A

Bio-Techne is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.